agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome

MeSH: C538055ORPHA: 83617

Overview

medical condition

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome, sourced from HPO and Orphanet clinical annotations.

Decreased total B cell countCleft palateMicrocephalyMicrognathiaLow-set earsUnderdeveloped nasal alaeChoanal stenosisBlepharophimosisParakeratosisSeborrheic dermatitisArachnodactylyGlobal developmental delayFailure to thriveRespiratory distressDecreased circulating total IgMCoronal craniosynostosisPostnatal growth retardationGastrostomy tube feeding in infancyEpidermal acanthosisSuperficial dermal perivascular inflammatory infiltrateInguinal herniaCryptorchidismMicropenisHydronephrosisNarrow mouthBrachyturricephalyRetrognathiaEpicanthusHigh foreheadWide nasal bridgeDownslanted palpebral fissuresThin ribsLong claviclesSingle transverse palmar creaseEczematoid dermatitisPruritusCholelithiasisAbsent speechIntrauterine growth retardationOverlapping toePyloric stenosisPulmonary hypoplasiaCoarse hairHepatomegalyDiffuse cerebral atrophyPancreatic hypoplasiaFused cervical vertebraeFlat foreheadCleft vertebral archBiliary hyperplasiaContracture of the distal interphalangeal joint of the fingersPerimembranous ventricular septal defectBrain atrophy

Classification & Codes

MeSH Code

C538055

Orphanet Code

ORPHA:83617
agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome
MeSHC538055
OrphanetORPHA:83617
Treatments0 drug(s)
Symptoms on record53 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO
agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome | OrphanDrug